Pain Control for Syringomyelia with Opioid Allergy
For patients with syringomyelia who are allergic to opioids, first-line treatment should include anticonvulsants (gabapentin or pregabalin) combined with muscle relaxants (tizanidine or baclofen) for effective management of both neuropathic pain and spasticity. 1
First-Line Medications
Anticonvulsants for Neuropathic Pain
- Gabapentin: Start at 300mg daily and titrate up to 1200-3600mg/day in divided doses
- Pregabalin: Start at 75mg twice daily and titrate up to 300-600mg/day in divided doses
These medications are considered first-line for neuropathic pain management in syringomyelia due to their ability to bind to calcium channels in the brain and spinal cord, inhibiting the release of excitatory neurotransmitters involved in pain transmission 1. Common side effects include somnolence, dizziness, and weight gain.
Muscle Relaxants for Spasticity
Tizanidine: 2-4mg every 6-8 hours as needed (maximum 36mg/day)
- Short-acting and particularly useful for times when relief of spasticity is most important 2
- Monitor for sedation, hypotension, and dry mouth
Baclofen: Start at 5mg three times daily, gradually increase to 20-25mg three times daily as needed
- Effective for spasticity management but requires careful monitoring for sedation 3
- Avoid abrupt discontinuation due to risk of withdrawal symptoms
Second-Line Treatments
Antidepressants
- Tricyclic antidepressants (amitriptyline, nortriptyline): 10-25mg at bedtime, gradually increasing to 50-150mg
- SNRIs (duloxetine, milnacipran): Duloxetine 30-60mg daily or milnacipran 50-100mg twice daily
These medications enhance monoaminergic neurotransmission and have strong evidence for analgesic effects in neuropathic pain 1. TCAs should be used cautiously in patients with cardiovascular disease due to potential side effects.
Topical Analgesics
For localized pain areas:
- Lidocaine patches: Apply to painful area for 12 hours on/12 hours off
- Capsaicin: Apply to affected area (start with low concentration)
Advanced Interventions for Refractory Pain
Interventional Procedures
If pain remains inadequately controlled with medication management:
- Intrathecal baclofen: Consider for severe spasticity that contributes to pain 1
- Neurosurgical procedures: Selective dorsal rhizotomy or dorsal root entry zone lesions may be considered for severe, refractory spasticity causing pain 1
Surgical Management
For patients with progressive neurological deterioration or pain unresponsive to medical management:
- Syringoperitoneal shunting: Has shown favorable results in alleviating pain (100% effectiveness in one study) 4
- Surgical correction of underlying causes: Particularly important if there are craniocervical junction abnormalities 5
Comprehensive Approach
Non-Pharmacological Interventions
- Physical therapy: Range-of-motion exercises, heat/cold application
- Cognitive behavioral therapy: For pain coping strategies
- Splinting: For management of spasticity-related contractures
Monitoring and Follow-up
- Assess pain control using validated pain scales
- Monitor for medication side effects, particularly sedation and cognitive impairment
- Regular MRI follow-up to assess syrinx progression
Important Considerations and Pitfalls
Avoid benzodiazepines: Guidelines specifically recommend against using diazepam or other benzodiazepines during stroke recovery due to potential deleterious effects on recovery and sedation 1
Medication timing: For spasticity management, schedule medication doses to coincide with times when spasticity relief is most needed 2
Sedation risk: Many effective medications for neuropathic pain and spasticity cause sedation. Monitor closely and consider morning-only dosing of stimulating medications if needed 1
Early intervention: Better outcomes are observed in patients with less severe neurological deficits, suggesting the need for early treatment 4
Combination therapy: Using multiple medication classes with different mechanisms of action often provides better pain control than monotherapy at higher doses
The treatment of syringomyelia-related pain remains challenging, but a systematic approach using anticonvulsants and muscle relaxants as first-line therapy, followed by appropriate adjuvant medications and interventional procedures when necessary, can provide significant pain relief and improved quality of life for these patients.